Skip to main content
Erschienen in: Supportive Care in Cancer 4/2016

01.04.2016 | Original Article

Dental abnormalities after chemotherapy in long-term survivors of childhood acute lymphoblastic leukemia 7–40 years after diagnosis

verfasst von: Petter Wilberg, Adriani Kanellopoulos, Ellen Ruud, Marianne Jensen Hjermstad, Sophie Dorothea Fosså, Bente Brokstad Herlofson

Erschienen in: Supportive Care in Cancer | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Factors associated with the long-term dental effects after chemotherapy for childhood malignancies have not been well described. The primary aims of this study were as follows: (1) to assess whether age at diagnosis and treatment-related factors are associated with dental defects in survivors of childhood acute lymphoblastic leukemia (ALL) and (2) to assess the survivors’ annual expenses for dental treatment compared to reference data.

Methods

This cross-sectional study enrolled 111 Norwegian survivors of ALL diagnosed before the age of 16. All of the subjects completed a questionnaire and underwent medical and oral examinations. Dental defects were registered according to the individual defect index, with 0 = no defects and 140 = anodontia, and the caries experience was registered according to the decayed-missing-filled teeth index (DMFT). Age-matched reference data were drawn from a national general population survey (n = 555).

Results

The mean age at examination was 29.1 years (SD 7.2), and mean follow-up period was 22.9 years (SD 7.3). In a regression model, diagnoses occurring at ≤5 years of age (B = −9.6, p < 0.001) and a cumulative dose of anthracyclines >120 mg/m2 (B = 11.5, p < 0.001) were strongly associated with more severe dental defects. Survivors treated after the age of 5 had experienced more caries than those treated at a younger age [DMFT 9.6 (SD 6.1) vs. 6.0 (SD 4.6), respectively; p = 0.001]. High annual expenses for dental treatment were reported by a larger percentage of the reference population compared to the survivor group (18 vs. 9 %, respectively; p = 0.02).

Conclusions

The age at diagnosis and the dose of anthracyclines appear to be strongly associated with the severity of dental defects, although few survivors reported high annual expenses for dental treatment. The increased risk of dental defects during adulthood should be communicated to ALL survivors.
Literatur
1.
Zurück zum Zitat Cancer Registry of Norway (2014) Cancer in Norway 2012—cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway, Oslo Cancer Registry of Norway (2014) Cancer in Norway 2012—cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway, Oslo
2.
Zurück zum Zitat Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G, Mellander L, Mäkipernaa A, Nygaard R, Saarinen-Pihkala UM, on behalf of the Nordic Society of Pediatric Haematology and Oncology (NOPHO) (2000) Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Leukemia 14:2267–2275. doi:10.1038/sj.leu.2401961 CrossRefPubMed Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G, Mellander L, Mäkipernaa A, Nygaard R, Saarinen-Pihkala UM, on behalf of the Nordic Society of Pediatric Haematology and Oncology (NOPHO) (2000) Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Leukemia 14:2267–2275. doi:10.​1038/​sj.​leu.​2401961 CrossRefPubMed
3.
Zurück zum Zitat Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, Dimitrova N, Jakab Z, Kaatsch P, Lacour B, Mallone S, Marcos-Gragera R, Minicozzi P, Sánchez-Pérez MJ, Sant M, Santaquilani M, Stiller C, Tavilla A, Trama A, Visser O, Peris-Bonet R (2014) Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. Lancet Oncol 15:35–47. doi:10.1016/s1470-2045(13)70548-5 CrossRefPubMed Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, Dimitrova N, Jakab Z, Kaatsch P, Lacour B, Mallone S, Marcos-Gragera R, Minicozzi P, Sánchez-Pérez MJ, Sant M, Santaquilani M, Stiller C, Tavilla A, Trama A, Visser O, Peris-Bonet R (2014) Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. Lancet Oncol 15:35–47. doi:10.​1016/​s1470-2045(13)70548-5 CrossRefPubMed
5.
Zurück zum Zitat Dahllöf G, Barr M, Bolme P, Modéer T, Lönnqvist B, Ringdèn O, Heimdahl A (1988) Disturbances in dental development after total body irradiation in bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol 65:41–44. doi:10.1016/0030-4220(88)90189-2 CrossRefPubMed Dahllöf G, Barr M, Bolme P, Modéer T, Lönnqvist B, Ringdèn O, Heimdahl A (1988) Disturbances in dental development after total body irradiation in bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol 65:41–44. doi:10.​1016/​0030-4220(88)90189-2 CrossRefPubMed
9.
Zurück zum Zitat Effinger KE, Migliorati CA, Hudson MM, McMullen KP, Kaste SC, Ruble K, Guilcher GM, Shah AJ, Castellino SM (2014) Oral and dental late effects in survivors of childhood cancer: a children’s oncology group report. Support Care Cancer. 22:2009–2019. doi:10.1007/s00520-014-2260-x PubMedCentralCrossRefPubMed Effinger KE, Migliorati CA, Hudson MM, McMullen KP, Kaste SC, Ruble K, Guilcher GM, Shah AJ, Castellino SM (2014) Oral and dental late effects in survivors of childhood cancer: a children’s oncology group report. Support Care Cancer. 22:2009–2019. doi:10.​1007/​s00520-014-2260-x PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Hölttä P, Hovi L, Saarinen-Pihkala UM, Peltola J, Alaluusua S (2005) Disturbed root development of permanent teeth after pediatric stem cell transplantation—dental root development after SCT. Cancer 103:1484–1493. doi:10.1002/cncr.20967 CrossRefPubMed Hölttä P, Hovi L, Saarinen-Pihkala UM, Peltola J, Alaluusua S (2005) Disturbed root development of permanent teeth after pediatric stem cell transplantation—dental root development after SCT. Cancer 103:1484–1493. doi:10.​1002/​cncr.​20967 CrossRefPubMed
11.
Zurück zum Zitat van der Pas-van Voskuilen IGM, Veerkamp JS, Raber-Durlacher JE, Bresters D, van Wijk AJ, Barasch A, McNeal S, Gortzak RA (2009) Long-term adverse effects of hematopoietic stem cell transplantation on dental development in children. Support Care Cancer 17:1169–1175. doi:10.1007/s00520-008-0567-1 CrossRefPubMed van der Pas-van Voskuilen IGM, Veerkamp JS, Raber-Durlacher JE, Bresters D, van Wijk AJ, Barasch A, McNeal S, Gortzak RA (2009) Long-term adverse effects of hematopoietic stem cell transplantation on dental development in children. Support Care Cancer 17:1169–1175. doi:10.​1007/​s00520-008-0567-1 CrossRefPubMed
12.
Zurück zum Zitat Hölttä P, Alaluusua S, Saarinen-Pihkala UM, Peltola J, Hovi L (2005) Agenesis and microdontia of permanent teeth as late adverse effects after stem cell transplantation in young children. Cancer 103:181–190. doi:10.1002/cncr.20762 CrossRefPubMed Hölttä P, Alaluusua S, Saarinen-Pihkala UM, Peltola J, Hovi L (2005) Agenesis and microdontia of permanent teeth as late adverse effects after stem cell transplantation in young children. Cancer 103:181–190. doi:10.​1002/​cncr.​20762 CrossRefPubMed
14.
Zurück zum Zitat Dahllöf G, Bågesund M, Ringdén O (1997) Impact of conditioning regimens on salivary function, caries-associated microorganisms and dental caries in children after bone marrow transplantation. A 4-year longitudinal study. Bone Marrow Transplant 20:479–483. doi:10.1038/sj.bmt.1700919 CrossRefPubMed Dahllöf G, Bågesund M, Ringdén O (1997) Impact of conditioning regimens on salivary function, caries-associated microorganisms and dental caries in children after bone marrow transplantation. A 4-year longitudinal study. Bone Marrow Transplant 20:479–483. doi:10.​1038/​sj.​bmt.​1700919 CrossRefPubMed
15.
Zurück zum Zitat Hsieh SG, Hibbert S, Shaw P, Ahern V, Arora M (2011) Association of cyclophosphamide use with dental developmental defects and salivary gland dysfunction in recipients of childhood antineoplastic therapy. Cancer 117:2219–2227. doi:10.1002/cncr.25704 CrossRefPubMed Hsieh SG, Hibbert S, Shaw P, Ahern V, Arora M (2011) Association of cyclophosphamide use with dental developmental defects and salivary gland dysfunction in recipients of childhood antineoplastic therapy. Cancer 117:2219–2227. doi:10.​1002/​cncr.​25704 CrossRefPubMed
16.
Zurück zum Zitat Kaste SC, Goodman P, Leisenring W, Stovall M, Hayashi RJ, Yeazel M, Beiraghi S, Hudson MM, Sklar CA, Robison LL, Baker KS (2009) Impact of radiation and chemotherapy on risk of dental abnormalities: a report from the Childhood Cancer Survivor Study. Cancer 115:5817–5827. doi:10.1002/cncr.24670 PubMedCentralCrossRefPubMed Kaste SC, Goodman P, Leisenring W, Stovall M, Hayashi RJ, Yeazel M, Beiraghi S, Hudson MM, Sklar CA, Robison LL, Baker KS (2009) Impact of radiation and chemotherapy on risk of dental abnormalities: a report from the Childhood Cancer Survivor Study. Cancer 115:5817–5827. doi:10.​1002/​cncr.​24670 PubMedCentralCrossRefPubMed
17.
Zurück zum Zitat Marec-Berard P, Azzi D, Chaux-Bodard AG, Lagrange H, Gourmet R, Bergeron C (2005) Long-term effects of chemotherapy on dental status in children treated for nephroblastoma. Pediatr Hematol Oncol 22:581–588. doi:10.1080/08880010500198848 CrossRefPubMed Marec-Berard P, Azzi D, Chaux-Bodard AG, Lagrange H, Gourmet R, Bergeron C (2005) Long-term effects of chemotherapy on dental status in children treated for nephroblastoma. Pediatr Hematol Oncol 22:581–588. doi:10.​1080/​0888001050019884​8 CrossRefPubMed
19.
Zurück zum Zitat Satoh H, Uesugi Y, Kawabata T, Mori K, Fujii F, Kashimoto Y, Kajimura T, Furuhama K (2001) Morphological classification of dental lesions induced by various antitumor drugs in mice. Toxicol Pathol 29:292–299. doi:10.1080/019262301316905246 CrossRefPubMed Satoh H, Uesugi Y, Kawabata T, Mori K, Fujii F, Kashimoto Y, Kajimura T, Furuhama K (2001) Morphological classification of dental lesions induced by various antitumor drugs in mice. Toxicol Pathol 29:292–299. doi:10.​1080/​0192623013169052​46 CrossRefPubMed
20.
Zurück zum Zitat Wogelius P, Dahllöf G, Gorst-Rasmussen A, Sørensen HT, Rosthøj S, Poulsen S (2008) A population-based observational study of dental caries among survivors of childhood cancer. Pediatr Blood Cancer 50:1221–1226. doi:10.1002/pbc.21464 CrossRefPubMed Wogelius P, Dahllöf G, Gorst-Rasmussen A, Sørensen HT, Rosthøj S, Poulsen S (2008) A population-based observational study of dental caries among survivors of childhood cancer. Pediatr Blood Cancer 50:1221–1226. doi:10.​1002/​pbc.​21464 CrossRefPubMed
22.
Zurück zum Zitat Zeller B, Tamnes CK, Kanellopoulos A, Amlien IK, Andersson S, Due-Tønnessen P, Fjell AM, Walhovd KB, Westlye LT, Ruud E (2013) Reduced neuroanatomic volumes in long-term survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 31:2078–2085. doi:10.1200/JCO.2012.47.4031 CrossRefPubMed Zeller B, Tamnes CK, Kanellopoulos A, Amlien IK, Andersson S, Due-Tønnessen P, Fjell AM, Walhovd KB, Westlye LT, Ruud E (2013) Reduced neuroanatomic volumes in long-term survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 31:2078–2085. doi:10.​1200/​JCO.​2012.​47.​4031 CrossRefPubMed
23.
Zurück zum Zitat Kanellopoulos A, Hamre HM, Dahl AA, Fosså SD, Ruud E (2013) Factors associated with poor quality of life in survivors of childhood acute lymphoblastic leukemia and lymphoma. Pediatr Blood Cancer 60:849–855. doi:10.1002/pbc.24375 CrossRefPubMed Kanellopoulos A, Hamre HM, Dahl AA, Fosså SD, Ruud E (2013) Factors associated with poor quality of life in survivors of childhood acute lymphoblastic leukemia and lymphoma. Pediatr Blood Cancer 60:849–855. doi:10.​1002/​pbc.​24375 CrossRefPubMed
24.
Zurück zum Zitat Hamre HM, Zeller B, Kanellopoulos A, Ruud E, Fosså SD, Loge JH, Aukrust P, Halvorsen B, Mollnes TE, Kiserud CE (2013) Serum cytokines and chronic fatigue in adults surviving after childhood leukemia and lymphoma. Brain Behav Immun 30:80–87. doi:10.1016/j.bbi.2013.01.006 CrossRefPubMed Hamre HM, Zeller B, Kanellopoulos A, Ruud E, Fosså SD, Loge JH, Aukrust P, Halvorsen B, Mollnes TE, Kiserud CE (2013) Serum cytokines and chronic fatigue in adults surviving after childhood leukemia and lymphoma. Brain Behav Immun 30:80–87. doi:10.​1016/​j.​bbi.​2013.​01.​006 CrossRefPubMed
25.
Zurück zum Zitat Zeller B, Ruud E, Loge JH, Kanellopoulos A, Hamre H, Godang K, Wyller VB (2014) Chronic fatigue in adult survivors of childhood cancer: associated symptoms, neuroendocrine markers, and autonomic cardiovascular responses. Psychosomatics 55:621–629. doi:10.1016/j.psym.2013.12.005 CrossRefPubMed Zeller B, Ruud E, Loge JH, Kanellopoulos A, Hamre H, Godang K, Wyller VB (2014) Chronic fatigue in adult survivors of childhood cancer: associated symptoms, neuroendocrine markers, and autonomic cardiovascular responses. Psychosomatics 55:621–629. doi:10.​1016/​j.​psym.​2013.​12.​005 CrossRefPubMed
28.
Zurück zum Zitat Moe P, Seip M, Finne P, Kolmannskog S (1984) Intermediate dose methotrexate in childhood acute lymphocytic leukemia. Pediatr Hematol Oncol 1:113–118. doi:10.3109/08880018409141718 Moe P, Seip M, Finne P, Kolmannskog S (1984) Intermediate dose methotrexate in childhood acute lymphocytic leukemia. Pediatr Hematol Oncol 1:113–118. doi:10.​3109/​0888001840914171​8
29.
Zurück zum Zitat Vaitkeviciene G, Forestier E, Hellebostad M, Heyman M, Jonsson OG, Lahteenmaki PM, Rosthoej S, Soderhall S, Schmiegelow K (2011) High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies. Eur J Haematol 86:38–46. doi:10.1111/j.1600-0609.2010.01522.x CrossRefPubMed Vaitkeviciene G, Forestier E, Hellebostad M, Heyman M, Jonsson OG, Lahteenmaki PM, Rosthoej S, Soderhall S, Schmiegelow K (2011) High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies. Eur J Haematol 86:38–46. doi:10.​1111/​j.​1600-0609.​2010.​01522.​x CrossRefPubMed
34.
35.
Zurück zum Zitat Hölttä P, Alaluusua S, Saarinen-Pihkala UM, Wolf J, Nystrom M, Hovi L (2002) Long-term adverse effects on dentition in children with poor-risk neuroblastoma treated with high-dose chemotherapy and autologous stem cell transplantation with or without total body irradiation. Bone Marrow Transplant 29:121–127. doi:10.1038/sj.bmt.1703330 CrossRefPubMed Hölttä P, Alaluusua S, Saarinen-Pihkala UM, Wolf J, Nystrom M, Hovi L (2002) Long-term adverse effects on dentition in children with poor-risk neuroblastoma treated with high-dose chemotherapy and autologous stem cell transplantation with or without total body irradiation. Bone Marrow Transplant 29:121–127. doi:10.​1038/​sj.​bmt.​1703330 CrossRefPubMed
38.
Zurück zum Zitat Maciel JC, de Castro CG, Jr BAL, Di Leone LP, da Silveira HE (2009) Oral health and dental anomalies in patients treated for leukemia in childhood and adolescence. Pediatr Blood Cancer 53:361–365. doi:10.1002/pbc.22108 CrossRefPubMed Maciel JC, de Castro CG, Jr BAL, Di Leone LP, da Silveira HE (2009) Oral health and dental anomalies in patients treated for leukemia in childhood and adolescence. Pediatr Blood Cancer 53:361–365. doi:10.​1002/​pbc.​22108 CrossRefPubMed
39.
Zurück zum Zitat Haavikko K (1970) The formation and the alveolar and clinical eruption of the permanent teeth. An orthopantomographic study. Suom Hammaslääk Toim 66:103–170PubMed Haavikko K (1970) The formation and the alveolar and clinical eruption of the permanent teeth. An orthopantomographic study. Suom Hammaslääk Toim 66:103–170PubMed
40.
Zurück zum Zitat Nordgarden H, Jensen JL, Storhaug K (2002) Reported prevalence of congenitally missing teeth in two Norwegian counties. Community Dent Health 19:258–261PubMed Nordgarden H, Jensen JL, Storhaug K (2002) Reported prevalence of congenitally missing teeth in two Norwegian counties. Community Dent Health 19:258–261PubMed
42.
Zurück zum Zitat Jensen SB, Pedersen AML, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NNF, Mello ALS, Muniz LV, Murdoch-Kinch CA, Nair RG, Napeñas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bültzingslöwen I, Weikel DS, Elting LS, Spijkervet FKL, Brennan MT (2010) A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer 18:1061–1079. doi:10.1007/s00520-010-0837-6 CrossRefPubMed Jensen SB, Pedersen AML, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NNF, Mello ALS, Muniz LV, Murdoch-Kinch CA, Nair RG, Napeñas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bültzingslöwen I, Weikel DS, Elting LS, Spijkervet FKL, Brennan MT (2010) A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer 18:1061–1079. doi:10.​1007/​s00520-010-0837-6 CrossRefPubMed
Metadaten
Titel
Dental abnormalities after chemotherapy in long-term survivors of childhood acute lymphoblastic leukemia 7–40 years after diagnosis
verfasst von
Petter Wilberg
Adriani Kanellopoulos
Ellen Ruud
Marianne Jensen Hjermstad
Sophie Dorothea Fosså
Bente Brokstad Herlofson
Publikationsdatum
01.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 4/2016
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2940-1

Weitere Artikel der Ausgabe 4/2016

Supportive Care in Cancer 4/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.